Anticoagulant-Associated Intracranial Hemorrhage in the Era of Reversal AgentsStroke 48:1432-1437, Steiner, T.,et al, 2017
FDA Approves Praxbind, the First Reversal Agent for the Anticoagulant PradaxaJAMA 314:2227, , 2015